首页> 外文期刊>Clinical and experimental pharmacology & physiology >Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells.
【24h】

Isoliquiritigenin inhibits the proliferation and induces the apoptosis of human non-small cell lung cancer a549 cells.

机译:异寡糖原蛋白抑制人非小细胞肺癌a549细胞的增殖并诱导其凋亡。

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

SUMMARY 1. Isoliquiritigenin (ISL) is a natural pigment with the simple chalcone structure 4,2',4'-trihydroxychalcone. In the present study, we report, for the first time, ISL-induced inhibition of the proliferation of the human non-small cell lung cancer A549 cell line. 2. The results showed that ISL not only inhibited A549 cell proliferation, but also induced apoptosis and blocked cell cycle progression in the G1 phase. An ELISA assay demonstrated that ISL significantly increased the expression of p53 and p21/WAF1 protein, which caused cell cycle arrest. 3. An enhancement in Fas and its two ligands, namely membrane-bound Fas ligand (mFasL) and soluble Fas ligand (sFasL), may be responsible for the apoptotic effect induced by ISL. 4. Taken together, the results indicate that the p53 and Fas/FasL apoptotic system may participate in the antiproliferative activity of ISL in A549 cells.
机译:概述1.异喹硫黄素(ISL)是具有简单查尔酮结构4,2',4'-三羟基查尔酮的天然色素。在本研究中,我们首次报道了ISL诱导的人非小细胞肺癌A549细胞株增殖抑制作用。 2.结果表明,ISL不仅抑制A549细胞增殖,而且在G1期诱导凋亡并阻断细胞周期进程。 ELISA分析表明,ISL显着增加了p53和p21 / WAF1蛋白的表达,从而导致细胞周期停滞。 3. Fas及其两个配体,即膜结合Fas配体(mFasL)和可溶性Fas配体(sFasL)的增强,可能与ISL诱导的细胞凋亡有关。 4.两者合计,结果表明p53和Fas / FasL凋亡系统可能参与了ISL在A549细胞中的抗增殖活性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号